The University of Hong Kong (HKU)-Queen Mary Hospital (QMH)

Hong Kong 999077

1 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, Hemophilia A, Hemophilia B, Psoriasis

Studies at this site

• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early